Newsletter

Hi and good evening,

I hope you are well this evening. I am sending you this email to inform you that Thursday’s Morning’s breaking new profile (complete with pictures) has just been uploaded and is now available online for your easy access and viewing. It can be accessed at the following link:

www.newpoweralert.com

We’ve started 2015 in record fashion as we’ve watched profiles run as high as 1185pct since the New Year began. Tonight’s play, VDRM, is a small biotech that owns a big patent-pending delivery method and a breakthrough pharma product known as TetraStem.

VDRM’s technology has already received high honors and awards from much of the Pharma community:

 - Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City.

- “Drug Store News Best New Product” as voted by key pharmacy industry decision makers at the ECRM Marketgate 2012 meetings held in Charlotte, NC.

Those are impressive honors for a company that closed today at just 016.

And there’s more… VDRM’s technology is FDA-registered and has already demonstrated it’s efficacy in several case studies.

A full report on these case studies can be found via the profile link above.

Right now VDRM is a small, little known biotech. What do you think will happen when a large number of traders find out about this hidden gem?

For several reasons including recent events, a potentially valuable pending patent and a National Institute of Health report that states VDRM’s Transdermal drug delivery market has some serious room to grow (it’s already valued at 31 Bln Dlrs in the US alone) we believe this new pick could be on track to soar to new heights!

So get ready, start your research right away. Start by visiting the link above to our full profile.

Thanks so much and enjoy your evening,

Q

IMPORTANT NOTICE AND DISCLAIMER

This is a paid email ad for the company or companies mentioned herein. This paid advertisement does not provide an analysis of any company's financial position, operations or prospects and as such this is not to be construed as a recommendation or a solicitation to buy or sell any security. Do not base any investment and/or financial decisions upon any of the materials found on our website or in our newsletter publication(s) such as this one. Market365, LLC, the publisher of this newsletter and the website(s) associated with this email publication and its affiliates and contractors are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice.

Our full disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list: Full Disclaimer

Release of Liability: Through use of this newsletter or viewing or using our website(s), you agree to hold Market365, its operators, owners, employees and/or contractors harmless and to completely release them from any and all liability due to any and all losses (monetary or otherwise), damages (monetary or otherwise) that may occur and/or that you may incur.

This is a paid email message: Market365 and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Market365 is a media and advertising firm that is often compensated by the companies profiled in our newsletter(s) and/or on our website(s). Compensation is received in cash via bank wire. We never receive compensation in shares. All compensation is disclosed in our newsletter(s) and/or on our website(s).

Compensation: We have been compensated two thousand five hundred dollars cash by a third party, Eden Media Group, for this marketing campaign of ViaDerma, Inc. All compensation is received via bank wire. We do not own any shares or hold any positions in ViaDerma, Inc.

Conflict of Interest: We do not investigate the background of any third party. The third party may have shares and may liquidate them, which may negatively affect the stock price. The above compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

Forward looking statements: The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.

Information: Market365 is committed to providing factual information on the companies that are profiled. However, we do not provide any assurances as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. Market365 has no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. To the fullest extent of the law, Market365 will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the alert, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). 

Third Party Websites: This email may provide hyperlinks to third party websites or access to third party content. Market365, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Market365 control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that Market365, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Market365, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

This email is based entirely upon information gathered from public information. Although the information contained in this e-mail is believed to be reliable, Market365 makes no warranties as to the accuracy of the content of this e-mail, expressly disclaims and accepts no liability for how readers may choose to utilize the content of this e-mail. Market365 does not verify the validity of any press releases in this electronic communication. Readers are strongly urged to independently verify all statements made in this email and to perform their own due diligence on this or any other advertised company, including but not limited to consulting with a qualified investment professional, reviewing the publicly available financial statements of, and other information about these featured companies and verifying that an investment in that company is appropriate and suitable for you.

Many companies have filed information with state securities regulators and many companies will supply prospective investors with additional information upon request. We encourage you to invest carefully and read investment information available at the websites of the SEC at www.sec.gov and FINRA at www.finra.org.